Simvastatin suppresses the activity of Th2 and Tc2 cells in atopic asthma and in COPD

J. Knobloch, Y. Yakin, B. Grensemann, S. Körber, D. Jungck, A. Koch (Bochum, Cologne, Germany)

Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Session: New treatments for cough, asthma, COPD and ILDs
Session type: Poster Discussion
Number: 1517
Disease area: Airway diseases

Congress or journal article abstract

Abstract

Rationale: Retrospective studies suggest simvastatin (SA) as an alternative anti-inflammatory therapy for asthma and COPD. It is unknown, which cell types are influenced by SA. SA might require activation to b-hydroxy-SA (BHSA) by carboxylesterases, which are primarily expressed in monocytes (compared to T cells).Hypothesis: SA reduces the release of Th1/Tc1 and Th2/Tc2 key cytokines (IFNg or IL-5 respectively).Methods: Pure circulating CD4+ and CD8+ T cells and T cell populations in peripheral blood mononuclear cells (PBMCs, which include monocytes) were activated ex vivo towards Th1/Tc1 or Th2/Tc2 and incubated with SA and BHSA (1-1000nM). Cytokines were measured by ELISA comparative between never-smokers (NS), smokers without (S) and with COPD and never-smokers with mild/moderate atopic asthma (A); n=9/7/14/10.Results: In the presence and absence of monocytes, IFNg was induced by activation of CD4+ or CD8+ cells towards Th1 or Tc1, respectively. Activation towards Th2 and Tc2 induced IL-5, which was increased in COPD vs. NS (p<0.05). BHSA but not SA reduced IL-5 in pure Th2 and Tc2 cells but not IFNg in pure Th1 and Tc1 cells - regardless of whether BHSA was added prior to or 24 h after T cell activation (each p<0.05). In the presence of monocytes (in PBMCs) SA reduced IL-5 from Th2/Tc2 cells without differences between cohorts and increased IFNg from Th1/Tc1 cells in S and COPD (each p<0.05) but not in NS and A.Discussion: SA requires activation in monocytes to modulate T cell cytokine expression. SA suppresses Th2/Tc2-associated cytokine production in asthma and COPD but might enhance Th1 inflammation in COPD. SA could have anti-inflammatory effects in asthma.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Knobloch, Y. Yakin, B. Grensemann, S. Körber, D. Jungck, A. Koch (Bochum, Cologne, Germany). Simvastatin suppresses the activity of Th2 and Tc2 cells in atopic asthma and in COPD. Eur Respir J 2014; 44: Suppl. 58, 1517

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Elevated GM-CSF in COPD may drive defective macrophage phenotype
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014

Expression of Th1, Th2 and Th17 cytokines in CD4+ T cells in peripheral blood of asthma patients
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014

The effect of budesonide on TLR expression in alveolar macrophages from smokers
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014


Functional phenotype of immune response and alveolar macrophages phenotype in pulmonary sarcoidosis
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014


Oxidative stress drives defective efferocytosis in COPD M2-like macrophages
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014

Systemic characterization of macrophage phenotypes in allergic airway inflammation
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014

Differential sensitivity of subsets of monocyte-derived macrophages to apoptosis; its impact on lung inflammation
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014

Dual role of M2 macrophages in asthma
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015

IL-33 and TSLP gene expression are increased in response to human rhinovirus 1B in HDM-treated murine bone marrow-derived macrophages
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014

Elevated IL-10 level but not cysteinyl leukotrienes (CysLT) release from leukocytes in vitro correlates with good response to treatment with montelukast in asthmatic patients
Source: International Congress 2014 – Asthma and COPD management
Year: 2014


Lymphocyte senescence in COPD is associated with loss of glucocorticoid receptor expression by cytotoxic/ pro-inflammatory lymphocytes
Source: International Congress 2014 – Effect of cigarette smoke on cell behaviour: cell biology, signalling and senescence
Year: 2014

Macrophage subsets in lung tissue of healthy controls and asthma patients
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015

Peripheral blood Th9 cells and IL-9 level in asthma patients with early and dual asthmatic response
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015



Additive anti-inflammatory effect of glucocorticoids and PDE4 inhibitors on COPD CD8 cells
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014

Synergistic effects of p38 MAPK inhibition with a corticosteroid in alveolar macrophages from corticosteroid insensitive asthma patients
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013

Biomass smoke particles induce cytokines and reduce phagocytosis by monocyte-derived macrophages
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014

Ration of IL1beta / IL1-receptor antagonist (RA) in alveolar macrophages of induced sputum of patients with asthma during long-term follow-up
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014


Mutually exclusive Th2 and Th17 bronchial gene expression signatures are associated with eosinophilia in asthma
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014

Soluble FasL and Fas+ lymphocytes in peripheral blood of non-smoking patients with COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014


Imbalance of immune response functional phenotype and alveolar macrophages phenotype in COPD
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014